Literature DB >> 22411732

Glu121-Lys319 salt bridge between catalytic and N-terminal domains is pivotal for the activity and stability of Escherichia coli aminopeptidase N.

Rajesh Gumpena1, Chandan Kishor, Roopa Jones Ganji, Nishant Jain, Anthony Addlagatta.   

Abstract

Escherichia coli aminopeptidase N (ePepN) belongs to the gluzincin family of M1 class metalloproteases that share a common primary structure with consensus zinc binding motif (HEXXH-(X18)-E) and an exopeptidase motif (GXMEN) in the active site. There is one amino acid, E121 in Domain I that blocks the extended active site grove of the thermolysin like catalytic domain (Domain II) limiting the substrate to S1 pocket. E121 forms a part of the S1 pocket, while making critical contact with the amino-terminus of the substrate. In addition, the carboxylate of E121 forms a salt bridge with K319 in Domain II. Both these residues are absolutely conserved in ePepN homologs. Analogous Glu-Asn pair in tricon interacting factor F3 (F3) and Gln-Asn pair in human leukotriene A(4) hydrolase (LTA(4) H) are also conserved in respective homologs. Mutation of either of these residues individually or together substantially reduced or entirely eliminated enzymatic activity. In addition, thermal denaturation studies suggest that the mutation at K319 destabilizes the protein as much as by 3.7 °C, while E121 mutants were insensitive. Crystal structure of E121Q mutant reveals that the enzyme is inactive due to the reduced S1 subsite volume. Together, data presented here suggests that ePepN, F3, and LTA(4) H homologs adopted a divergent evolution that includes E121-K319 or its analogous pairs, and these cannot be interchanged.
Copyright © 2012 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22411732      PMCID: PMC3403470          DOI: 10.1002/pro.2060

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  26 in total

1.  Announcing the worldwide Protein Data Bank.

Authors:  Helen Berman; Kim Henrick; Haruki Nakamura
Journal:  Nat Struct Biol       Date:  2003-12

2.  An efficient one-step site-directed and site-saturation mutagenesis protocol.

Authors:  Lei Zheng; Ulrich Baumann; Jean-Louis Reymond
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

3.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

4.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site.

Authors:  Anthony Addlagatta; Leslie Gay; Brian W Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

6.  Crystal structure of aminopeptidase N (proteobacteria alanyl aminopeptidase) from Escherichia coli and conformational change of methionine 260 involved in substrate recognition.

Authors:  Kiyoshi Ito; Yoshitaka Nakajima; Yuko Onohara; Masahide Takeo; Kanako Nakashima; Futoshi Matsubara; Takashi Ito; Tadashi Yoshimoto
Journal:  J Biol Chem       Date:  2006-08-02       Impact factor: 5.157

7.  Crystal structures of the tricorn interacting factor F3 from Thermoplasma acidophilum, a zinc aminopeptidase in three different conformations.

Authors:  Otto J P Kyrieleis; Peter Goettig; Reiner Kiefersauer; Robert Huber; Hans Brandstetter
Journal:  J Mol Biol       Date:  2005-04-26       Impact factor: 5.469

8.  Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro.

Authors:  Soma Sengupta; Peleg M Horowitz; Stanislav L Karsten; George R Jackson; Daniel H Geschwind; Yifan Fu; Robert W Berry; Lester I Binder
Journal:  Biochemistry       Date:  2006-12-19       Impact factor: 3.162

9.  Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation.

Authors:  M M Thunnissen; P Nordlund; J Z Haeggström
Journal:  Nat Struct Biol       Date:  2001-02

Review 10.  Leukotriene A4 hydrolase as a target for cancer prevention and therapy.

Authors:  X Chen; S Wang; N Wu; C S Yang
Journal:  Curr Cancer Drug Targets       Date:  2004-05       Impact factor: 3.428

View more
  5 in total

1.  Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N.

Authors:  Roopa Jones Ganji; Ravikumar Reddi; Rajesh Gumpena; Anil Kumar Marapaka; Tarun Arya; Priyanka Sankoju; Supriya Bhukya; Anthony Addlagatta
Journal:  Protein Sci       Date:  2015-04-08       Impact factor: 6.725

2.  Human Naa50 Protein Displays Broad Substrate Specificity for Amino-terminal Acetylation: DETAILED STRUCTURAL AND BIOCHEMICAL ANALYSIS USING TETRAPEPTIDE LIBRARY.

Authors:  Ravikumar Reddi; Venkateshwarlu Saddanapu; Dinesh Kumar Chinthapalli; Priyanka Sankoju; Prabhakar Sripadi; Anthony Addlagatta
Journal:  J Biol Chem       Date:  2016-08-02       Impact factor: 5.157

Review 3.  Computational enzyme design approaches with significant biological outcomes: progress and challenges.

Authors:  Xiaoman Li; Ziding Zhang; Jiangning Song
Journal:  Comput Struct Biotechnol J       Date:  2012-10-17       Impact factor: 7.271

4.  Deciphering the Role of Multiple Thioredoxin Fold Proteins of Leptospirillum sp. in Oxidative Stress Tolerance.

Authors:  Daniela González; Pamela Álamos; Matías Rivero; Omar Orellana; Javiera Norambuena; Renato Chávez; Gloria Levicán
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

5.  Structure-guided systems-level engineering of oxidation-prone methionine residues in catalytic domain of an alkaline α-amylase from Alkalimonas amylolytica for significant improvement of both oxidative stability and catalytic efficiency.

Authors:  Haiquan Yang; Long Liu; Hyun-dong Shin; Jianghua Li; Guocheng Du; Jian Chen
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.